277 related articles for article (PubMed ID: 26521072)
21. Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation.
Mothes R; Ulbricht C; Leben R; Günther R; Hauser AE; Radbruch H; Niesner R
Front Mol Biosci; 2020; 7():62. PubMed ID: 32426367
[TBL] [Abstract][Full Text] [Related]
22. Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics.
Lee G; Hasan M; Kwon OS; Jung BH
Neuroscience; 2019 Sep; 416():74-87. PubMed ID: 31376423
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitis.
Makar TK; Guda PR; Ray S; Andhavarapu S; Keledjian K; Gerzanich V; Simard JM; Nimmagadda VKC; Bever CT
Sci Rep; 2023 Apr; 13(1):5635. PubMed ID: 37024509
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
Guo X; Nakamura K; Kohyama K; Harada C; Behanna HA; Watterson DM; Matsumoto Y; Harada T
Neurosci Res; 2007 Dec; 59(4):457-66. PubMed ID: 17920148
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis.
Kauppinen TM; Suh SW; Genain CP; Swanson RA
J Neurosci Res; 2005 Jul; 81(2):190-8. PubMed ID: 15931673
[TBL] [Abstract][Full Text] [Related]
27. NOX enzymes in the central nervous system: from signaling to disease.
Sorce S; Krause KH
Antioxid Redox Signal; 2009 Oct; 11(10):2481-504. PubMed ID: 19309263
[TBL] [Abstract][Full Text] [Related]
28. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
Guzik TJ; Harrison DG
Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
[TBL] [Abstract][Full Text] [Related]
29. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
30. The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Fiebiger SM; Bros H; Grobosch T; Janssen A; Chanvillard C; Paul F; Dörr J; Millward JM; Infante-Duarte C
J Neuroimmunol; 2013 Sep; 262(1-2):66-71. PubMed ID: 23871488
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod.
Mishra MK; Wang J; Silva C; Mack M; Yong VW
Am J Pathol; 2012 Aug; 181(2):642-51. PubMed ID: 22749771
[TBL] [Abstract][Full Text] [Related]
32. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair.
Mohajeri M; Sadeghizadeh M; Najafi F; Javan M
Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978
[TBL] [Abstract][Full Text] [Related]
33. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
34. Radical changes in multiple sclerosis pathogenesis.
van Horssen J; Witte ME; Schreibelt G; de Vries HE
Biochim Biophys Acta; 2011 Feb; 1812(2):141-50. PubMed ID: 20600869
[TBL] [Abstract][Full Text] [Related]
35. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
36. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
37. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
[TBL] [Abstract][Full Text] [Related]
38. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
Wang P; Wang ZW; Lin FH; Han Z; Hou ST; Zheng RY
Biochem Biophys Res Commun; 2011 Mar; 406(1):152-7. PubMed ID: 21303658
[TBL] [Abstract][Full Text] [Related]
39. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration.
Massa MG; David C; Jörg S; Berg J; Gisevius B; Hirschberg S; Linker RA; Gold R; Haghikia A
Am J Pathol; 2017 Jul; 187(7):1613-1622. PubMed ID: 28634006
[TBL] [Abstract][Full Text] [Related]
40. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
